SONN
Price
$1.37
Change
-$0.05 (-3.52%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
4.17M
VANI
Price
$1.03
Change
-$0.00 (-0.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
61.02M
24 days until earnings call
Ad is loading...

SONN vs VANI

Header iconSONN vs VANI Comparison
Open Charts SONN vs VANIBanner chart's image
Sonnet BioTherapeutics Holdings
Price$1.37
Change-$0.05 (-3.52%)
Volume$501
Capitalization4.17M
Vivani Medical
Price$1.03
Change-$0.00 (-0.00%)
Volume$100
Capitalization61.02M
SONN vs VANI Comparison Chart
Loading...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SONN vs. VANI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SONN is a Buy and VANI is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (SONN: $1.36 vs. VANI: $1.03)
Brand notoriety: SONN and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SONN: 70% vs. VANI: 47%
Market capitalization -- SONN: $4.17M vs. VANI: $61.02M
SONN [@Biotechnology] is valued at $4.17M. VANI’s [@Biotechnology] market capitalization is $61.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SONN’s FA Score shows that 1 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • SONN’s FA Score: 1 green, 4 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, SONN is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SONN’s TA Score shows that 4 TA indicator(s) are bullish while VANI’s TA Score has 4 bullish TA indicator(s).

  • SONN’s TA Score: 4 bullish, 5 bearish.
  • VANI’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VANI is a better buy in the short-term than SONN.

Price Growth

SONN (@Biotechnology) experienced а +7.94% price change this week, while VANI (@Biotechnology) price change was -2.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

SONN is expected to report earnings on Nov 29, 2023.

VANI is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($61M) has a higher market cap than SONN($4.17M). SONN YTD gains are higher at: -6.849 vs. VANI (-11.207). SONN has higher annual earnings (EBITDA): -13.33M vs. VANI (-24.03M). VANI has more cash in the bank: 19.6M vs. SONN (4.86M). SONN has less debt than VANI: SONN (111K) vs VANI (19.7M). SONN has higher revenues than VANI: SONN (1M) vs VANI (0).
SONNVANISONN / VANI
Capitalization4.17M61M7%
EBITDA-13.33M-24.03M56%
Gain YTD-6.849-11.20761%
P/E Ratio0.29N/A-
Revenue1M0-
Total Cash4.86M19.6M25%
Total Debt111K19.7M1%
FUNDAMENTALS RATINGS
SONN vs VANI: Fundamental Ratings
SONN
VANI
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
9378
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SONN's Valuation (23) in the null industry is in the same range as VANI (45). This means that SONN’s stock grew similarly to VANI’s over the last 12 months.

SONN's Profit vs Risk Rating (100) in the null industry is in the same range as VANI (100). This means that SONN’s stock grew similarly to VANI’s over the last 12 months.

SONN's SMR Rating (98) in the null industry is in the same range as VANI (100). This means that SONN’s stock grew similarly to VANI’s over the last 12 months.

VANI's Price Growth Rating (78) in the null industry is in the same range as SONN (93). This means that VANI’s stock grew similarly to SONN’s over the last 12 months.

SONN's P/E Growth Rating (96) in the null industry is in the same range as VANI (100). This means that SONN’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SONNVANI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 8 days ago
81%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 21 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVCR18.550.78
+4.39%
NovoCure Limited
MDGL319.9311.14
+3.61%
Madrigal Pharmaceuticals
NPCE11.250.34
+3.12%
Neuropace
MODD0.940.03
+2.73%
Modular Medical
UPS98.921.71
+1.76%
United Parcel Service

SONN and

Correlation & Price change

A.I.dvisor tells us that SONN and VANI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SONN and VANI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-4.23%
VANI - SONN
27%
Poorly correlated
N/A
ABSI - SONN
27%
Poorly correlated
+0.94%
DWTX - SONN
27%
Poorly correlated
-3.58%
PRME - SONN
26%
Poorly correlated
-1.69%
IGMS - SONN
26%
Poorly correlated
-0.72%
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
60%
Loosely correlated
+9.49%
ADIL - VANI
37%
Loosely correlated
+2.13%
OVID - VANI
36%
Loosely correlated
+3.63%
AXSM - VANI
36%
Loosely correlated
+1.13%
MGTX - VANI
34%
Loosely correlated
+0.92%
More